Is The Worst Over For Emergent Biosolutions Stock?

Emergent Biosolutions has been in the news lately but for the wrong reasons. Earlier this month, we advised caution on EBS stock when it was revealed that a “human error” in the company’s plant resulted in the contamination of a batch of Johnson & Johnson’s (NYSE: JNJ) Covid-19 vaccine…

Exit mobile version